Company CVAbout Panchsheel Organics Ltd 
Panchsheel Organics Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Incorporated as a private limited company in 1989, Panchsheel Organics Limited (POL) was later converted into a public limited company in 1992. Company is manufacturer and exporter of Active Pharma Ingredients (APIs), Intermediates & Finished Formulations (both Human & Veterinary), having a wide experience of more than three decades in the healthcare field.
Company Coordinates
Company Details
B-6 & B-7 Sector - C, Industrial Estate Sanwer Road Indore Madhya Pradesh : 452015
Registrar Details
Purva Shareregistry (India) Pvt Ltd , Gala No 9, Shiv Shakti, Industrial Estate,Sitaram Mill Comp., J R Boricha Marg, Lower Parel [E], Mumbai
Capital StructureCapital Structure
Present Equity Capital
INR 13.17 Cr
Number of Shares
1.32 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
07-Mar-2024
1.32
13.17
1390000
10
Conversion of Warrants
08-Sep-2022
1.18
11.78
1750950
10
Preferential basis
06-Dec-2021
1
10.03
5015400
10
Bonus Issue
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Rajesh Abhaychand Turakhia (16.16%)
Highest Public shareholder
Michael Dsouza (1.94%)
Individual Investors Holdings
33.12%
Board of Directors
Management
Designation
Remuneration
Mahendra Abhaychand Turakhia
Chairman & Managing Director
0
Kishore Abhaychand Turakhia
Whole-time Director
0
Diwakar Mani Tripathi
Independent Director
0
Shambhnath Chakravarti
Independent Director
0
Darshana Vishal Shah
Independent Director
0
Rajesh Turakhia
Director
0
Nikhil Borana
Company Sec. & Compli. Officer
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Bulk Drug
38.37
89.93%
Bulk Drug - Traded
1.70
3.98%
DEPB Licence
1.46
3.42%
Bulk Drug
Bulk Drug
Bulk Drug - Traded
Bulk Drug - Traded
DEPB Licence
DEPB Licence
Stock DNARevenue and Profits:
Net Sales:
25 Cr
(Quarterly Results - Sep 2025)
Net Profit:
3 Cr
Pharmaceuticals & Biotechnology
INR 146 Cr (Micro Cap)
12.00
33
2.81%
0.00
8.90%
1.09
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
